ImmunoGen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ImmunoGen and buy or sell other stocks, options, and ETFs commission-free!About IMGN
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.
CEOMark Joseph Enyedy
CEOMark Joseph Enyedy
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded1981
Founded1981
Employees—
Employees—
IMGN Key Statistics
Market cap8.30B
Market cap8.30B
Price-Earnings ratio-104.24
Price-Earnings ratio-104.24
Dividend yield—
Dividend yield—
Average volume10.88M
Average volume10.88M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$31.25
52 Week high$31.25
52 Week low$3.61
52 Week low$3.61